{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:21:28Z","timestamp":1790486488335,"version":"4.1.0"},"reference-count":236,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00246","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T03:09:32Z","timestamp":1470280172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":143,"title":["Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Michael D.","family":"Lovelace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Varney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio F.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Li","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saparna","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/1381612822666151215095940","article-title":"Tryptophan catabolites and their impact on multiple sclerosis progression","volume":"22","author":"Watzlawik","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2009.01.012","article-title":"Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging","volume":"282","author":"Chard","year":"2009","journal-title":"J Neurol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1474-4422(05)70166-6","article-title":"Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing","volume":"4","author":"Mitchell","year":"2005","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/archneur.59.5.726","article-title":"Current immunotherapy for demyelinating diseases","volume":"59","author":"Bashir","year":"2002","journal-title":"Arch Neurol"},{"key":"B6","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"issue":"Pt 5","key":"B7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"B8","first-page":"611","article-title":"Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria","volume":"152","author":"Sanni","year":"1998","journal-title":"Am J Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up?","volume":"13","author":"Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","article-title":"The kynurenine pathway of tryptophan degradation as a drug target","volume":"4","author":"Schwarcz","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0131389","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1389200217666151222155043","article-title":"Brain aging and disorders of the central nervous system: kynurenines and drug metabolism","volume":"17","author":"Torok","year":"2016","journal-title":"Curr Drug Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fimmu.2014.00673","article-title":"Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors","volume":"5","author":"Platten","year":"2014","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"B17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2014.00585","article-title":"IDO2 in immunomodulation and autoimmune disease","volume":"5","author":"Prendergast","year":"2014","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-014-0204-5","article-title":"Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies","volume":"11","author":"Sundaram","year":"2014","journal-title":"J Neuroinflammation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/107999001317205231","article-title":"IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment","volume":"21","author":"Guillemin","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1179\/135100000101535375","article-title":"Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis","volume":"5","author":"Guillemin","year":"2000","journal-title":"Redox Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2004","journal-title":"Glia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","article-title":"The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen","volume":"16","author":"Lestage","year":"2002","journal-title":"Brain Behav Immun"},{"key":"B27","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1016\/S0021-9258(18)53504-3","article-title":"Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and\u2009-alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor","volume":"268","author":"Hassanain","year":"1993","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1006\/cyto.1999.0661","article-title":"Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells","volume":"12","author":"Babcock","year":"2000","journal-title":"Cytokine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1189\/jlb.0105029","article-title":"Profiling dendritic cell maturation with dedicated microarrays","volume":"78","author":"McIlroy","year":"2005","journal-title":"J Leukoc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:82313::AID-IMMU23133.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1172\/JCI21275","article-title":"Inhibition of experimental asthma by indoleamine 2,3-dioxygenase","volume":"114","author":"Hayashi","year":"2004","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/jir.1997.17.387","article-title":"Potentiation of interferon-induced indoleamine 2,3-dioxygenase mRNA in human mononuclear phagocytes by lipopolysaccharide and interleukin-1","volume":"17","author":"Hissong","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/107999000312306","article-title":"Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently","volume":"20","author":"Currier","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/107999003322277829","article-title":"Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha","volume":"23","author":"Robinson","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.1997.17.589","article-title":"Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha","volume":"17","author":"Pemberton","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1046\/j.1471-4159.1996.66030996.x","article-title":"Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells","volume":"66","author":"Alberati-Giani","year":"1996","journal-title":"J Neurochem"},{"issue":"Pt 2","key":"B38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types","volume":"326","author":"Heyes","year":"1997","journal-title":"Biochem J"},{"key":"B39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1096\/fasebj.12.10.881","article-title":"Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques","volume":"12","author":"Heyes","year":"1998","journal-title":"FASEB J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.4049\/jimmunol.150.9.4031","article-title":"Picolinic acid, a catabolite of l-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages","volume":"150","author":"Melillo","year":"1993","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1016\/S0021-9258(17)37169-7","article-title":"Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid","volume":"269","author":"Melillo","year":"1994","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jez.1402680204","article-title":"Regulation of mammalian brain cell volume","volume":"268","author":"Law","year":"1994","journal-title":"J Exp Zool"},{"issue":"3","key":"B45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbadis.2015.10.014","article-title":"Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease","volume":"1862","author":"Simon","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/00005072-199810000-00001","article-title":"Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis","volume":"57","author":"Weller","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jnen\/59.7.561","article-title":"Choroid plexus in the central nervous system: biology and physiopathology","volume":"59","author":"Strazielle","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/glia.440140102","article-title":"The ependyma: a protective barrier between brain and cerebrospinal fluid","volume":"14","author":"Del Bigio","year":"1995","journal-title":"Glia"},{"issue":"Suppl","key":"B49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1679\/aohc.52.Suppl_195","article-title":"The cerebrospinal fluid-contacting neuron: a peculiar cell type of the central nervous system. Immunocytochemical aspects","volume":"52","author":"Vigh-Teichmann","year":"1989","journal-title":"Arch Histol Cytol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","article-title":"A new look at cerebrospinal fluid circulation","volume":"11","author":"Brinker","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"B51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fncel.2015.00136","article-title":"The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system","volume":"9","author":"Marques","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e2559","DOI":"10.1371\/journal.pone.0002559","article-title":"Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis","volume":"3","author":"Kuenz","year":"2008","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e17988","DOI":"10.1371\/journal.pone.0017988","article-title":"Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients","volume":"6","author":"Fritzsching","year":"2011","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s11095-005-6039-0","article-title":"Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route","volume":"22","author":"Johanson","year":"2005","journal-title":"Pharm Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/135245859800400302","article-title":"Cerebrospinal fluid \u2013 physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult Scler"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/124.11.2169","article-title":"Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis","volume":"124","author":"Cepok","year":"2001","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ics.2007.07.012","article-title":"Mass spectrometric detection of quinolinic acid in microdissected Alzheimer\u2019s disease plaques","volume":"1304","author":"Guillemin","year":"2007","journal-title":"Int Congr Ser"},{"key":"B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int J Tryptophan Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4615-0135-0_19","article-title":"Quinolinic acid in the pathogenesis of Alzheimer\u2019s disease","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00002030-199804000-00003","article-title":"Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex","volume":"12","author":"Kerr","year":"1998","journal-title":"AIDS"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1212\/WNL.49.6.1671","article-title":"Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages","volume":"49","author":"Kerr","year":"1997","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ics.2007.07.011","article-title":"Characterization of the kynurenine pathway in primary human oligodendrocytes","volume":"1304","author":"Lim","year":"2007","journal-title":"Int Congr Ser"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J Neurochem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"Komori","year":"2015","journal-title":"Ann Neurol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/ene.12579","article-title":"Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis","volume":"22","author":"Villar","year":"2015","journal-title":"Eur J Neurol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1177\/1352458515574148","article-title":"Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis","volume":"21","author":"Modvig","year":"2015","journal-title":"Mult Scler"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1046\/j.1471-4159.1995.64031192.x","article-title":"Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis","volume":"64","author":"Flanagan","year":"1995","journal-title":"J Neurochem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis","volume":"129","author":"Sakurai","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jnnp.42.7.640","article-title":"Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases","volume":"42","author":"Monaco","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci Lett"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"B73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4137\/IJTR.S12536","article-title":"Kynurenic acid in the digestive system-new facts, new challenges","volume":"6","author":"Turski","year":"2013","journal-title":"Int J Tryptophan Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","article-title":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms","volume":"51","author":"Aeinehband","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1111\/j.1365-2567.2008.02999.x","article-title":"Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP","volume":"128","author":"Hedegaard","year":"2009","journal-title":"Immunology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.11.005","article-title":"Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment","volume":"266","author":"Sadowska-Bartosz","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri1130","article-title":"Three or more routes for leukocyte migration into the central nervous system","volume":"3","author":"Ransohoff","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B79","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.145.8.2474","article-title":"Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro","volume":"145","author":"Sedgwick","year":"1990","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0002-9440(10)64982-6","article-title":"Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity","volume":"156","author":"Hu","year":"2000","journal-title":"Am J Pathol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1460-9568.2007.05792.x","article-title":"CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology","volume":"26","author":"Smorodchenko","year":"2007","journal-title":"Eur J Neurosci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","article-title":"How do immune cells overcome the blood-brain barrier in multiple sclerosis?","volume":"585","author":"Larochelle","year":"2011","journal-title":"FEBS Lett"},{"issue":"3","key":"B83","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","article-title":"Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke","volume":"1862","author":"Lopes Pinheiro","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B84","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1750-3639.1998.tb00170.x","article-title":"Microvascular and cellular responses in the retina of rats with acute experimental allergic encephalomyelitis (EAE)","volume":"8","author":"Hu","year":"1998","journal-title":"Brain Pathol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0730-725X(85)90006-2","article-title":"Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imaging","volume":"3","author":"Runge","year":"1985","journal-title":"Magn Reson Imaging"},{"issue":"Pt 4","key":"B86","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/brain\/111.4.927","article-title":"Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis","volume":"111","author":"Miller","year":"1988","journal-title":"Brain"},{"issue":"Pt 5","key":"B87","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"key":"B88","first-page":"1033","article-title":"Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells","volume":"137","author":"Claudio","year":"1990","journal-title":"Am J Pathol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF00688172","article-title":"Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis","volume":"78","author":"Lossinsky","year":"1989","journal-title":"Acta Neuropathol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/WNL.51.6.1689","article-title":"A serial study of new MS lesions and the white matter from which they arise","volume":"51","author":"Goodkin","year":"1998","journal-title":"Neurology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.1434","article-title":"Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination","volume":"201","author":"Kirk","year":"2003","journal-title":"J Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/BST0370329","article-title":"The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis","volume":"37","author":"McQuaid","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"B93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1750-3639.2002.tb00430.x","article-title":"Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis","volume":"12","author":"Plumb","year":"2002","journal-title":"Brain Pathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.nbd.2005.06.012","article-title":"Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis","volume":"20","author":"Vos","year":"2005","journal-title":"Neurobiol Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ana.410430616","article-title":"Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis","volume":"43","author":"Filippi","year":"1998","journal-title":"Ann Neurol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nicl.2013.12.001","article-title":"Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI","volume":"4","author":"Cramer","year":"2014","journal-title":"Neuroimage Clin"},{"key":"B97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/RLI.0b013e31823bfc97","article-title":"Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T","volume":"47","author":"Ingrisch","year":"2012","journal-title":"Invest Radiol"},{"key":"B98","first-page":"45","article-title":"The natural history of optic neuritis","volume":"3","author":"Atkins","year":"2006","journal-title":"Rev Neurol Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awv203","article-title":"Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis","volume":"138","author":"Cramer","year":"2015","journal-title":"Brain"},{"key":"B100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-319-18497-5_5","article-title":"Hypoxia and inflammation-induced disruptions of the blood-brain and blood-cerebrospinal fluid barriers assessed using a novel T1-based MRI method","volume":"121","author":"Nathoo","year":"2016","journal-title":"Acta Neurochir Suppl"},{"key":"B101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00281-010-0216-x","article-title":"Knocking at the brain\u2019s door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures","volume":"32","author":"Kawakami","year":"2010","journal-title":"Semin Immunopathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"Mandi","year":"2012","journal-title":"J Neural Transm (Vienna)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.4049\/jimmunol.174.5.2910","article-title":"A crucial role for tryptophan catabolism at the host\/Candida albicans interface","volume":"174","author":"Bozza","year":"2005","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"key":"B108","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1432-2277.2004.00031.x","article-title":"Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo","volume":"18","author":"Bauer","year":"2005","journal-title":"Transpl Int"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4049\/jimmunol.177.1.130","article-title":"Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO","volume":"177","author":"Belladonna","year":"2006","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","article-title":"3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system","volume":"34","author":"Colin-Gonzalez","year":"2013","journal-title":"Neurotoxicology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 cells and autoimmune encephalomyelitis (EAE\/MS)","volume":"57","author":"Aranami","year":"2008","journal-title":"Allergol Int"},{"key":"B115","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/intimm\/dxh003","article-title":"Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis","volume":"16","author":"Xiao","year":"2004","journal-title":"Int Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"key":"B119","doi-asserted-by":"publisher","first-page":"18270","DOI":"10.3390\/ijms160818270","article-title":"Kynurenines and multiple sclerosis: the dialogue between the immune system and the central nervous system","volume":"16","author":"Rajda","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF00869773","article-title":"Interleukin-2, soluble interleukin-2-receptor, neopterin, l-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis","volume":"241","author":"Ott","year":"1993","journal-title":"J Neurol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"IDO expression in the brain: a double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2014.05.010","article-title":"Monocyte homeostasis and the plasticity of inflammatory monocytes","volume":"291","author":"Mitchell","year":"2014","journal-title":"Cell Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","article-title":"Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease","volume":"113","author":"King","year":"2009","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat Neurosci"},{"key":"B126","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ajpath.2012.05.011","article-title":"Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod","volume":"181","author":"Mishra","year":"2012","journal-title":"Am J Pathol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jneuroim.2015.11.004","article-title":"Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis","volume":"290","author":"Moreno","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"Pt 3","key":"B128","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"B129","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0002-9440(10)63017-9","article-title":"CCR1+\/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis","volume":"159","author":"Trebst","year":"2001","journal-title":"Am J Pathol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e59749","DOI":"10.1371\/journal.pone.0059749","article-title":"Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer\u2019s disease brain","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"B136","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1471-4159.2010.07159.x","article-title":"Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis","volume":"118","author":"Chen","year":"2011","journal-title":"J Neurochem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1046\/j.1471-4159.2001.00335.x","article-title":"Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid","volume":"77","author":"Chiarugi","year":"2001","journal-title":"J Neurochem"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"B140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0003-2697(86)90595-6","article-title":"A radioenzymatic assay for quinolinic acid","volume":"158","author":"Foster","year":"1986","journal-title":"Anal Biochem"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1742-4658.2012.08493.x","article-title":"Quinolinic acid: neurotoxicity","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"B142","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/IJTR.S7052","article-title":"Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons","volume":"4","author":"Braidy","year":"2011","journal-title":"Int J Tryptophan Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0304-3940(90)90160-B","article-title":"Kynurenic acid antagonizes hippocampal quinolinic acid neurotoxicity: behavioral and histological evaluation","volume":"120","author":"Lekieffre","year":"1990","journal-title":"Neurosci Lett"},{"key":"B144","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J Neurol Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","article-title":"Mechanisms and functional implications of adult neurogenesis","volume":"132","author":"Zhao","year":"2008","journal-title":"Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e14698","DOI":"10.1371\/journal.pone.0014698","article-title":"Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)","volume":"6","author":"Croitoru-Lamoury","year":"2011","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1600-065X.2010.00915.x","article-title":"Control of immune response by amino acid metabolism","volume":"236","author":"Grohmann","year":"2010","journal-title":"Immunol Rev"},{"key":"B149","doi-asserted-by":"publisher","first-page":"104024","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitron","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"B150","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40064-015-0826-9","article-title":"Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro","volume":"4","author":"Sekine","year":"2015","journal-title":"Springerplus"},{"key":"B151","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0006-8993(01)02017-0","article-title":"Oligodendrocyte killing by quinolinic acid in vitro","volume":"896","author":"Cammer","year":"2001","journal-title":"Brain Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0361-9230(02)00830-4","article-title":"Protection of cultured oligodendrocytes against tumor necrosis factor-alpha by the antioxidants coenzyme Q(10) and N-acetyl cysteine","volume":"58","author":"Cammer","year":"2002","journal-title":"Brain Res Bull"},{"key":"B153","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00001756-200002070-00005","article-title":"Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain","volume":"11","author":"Tavares","year":"2000","journal-title":"Neuroreport"},{"key":"B154","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int"},{"key":"B155","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","article-title":"Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing AKT phosphorylation and glutamate uptake","volume":"16","author":"Piermartiri","year":"2009","journal-title":"Neurotox Res"},{"key":"B156","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1042\/bj2680437","article-title":"Glutamine synthesis from aspartate in guinea-pig renal cortex","volume":"268","author":"Baverel","year":"1990","journal-title":"Biochem J"},{"key":"B157","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-2094-6-36","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer\u2019s disease","volume":"6","author":"Ting","year":"2009","journal-title":"J Neuroinflammation"},{"key":"B158","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-4613-0381-7_38","article-title":"Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain","volume":"398","author":"Goda","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.lfs.2006.11.031","article-title":"Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid","volume":"80","author":"Muller","year":"2007","journal-title":"Life Sci"},{"key":"B160","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0006-8993(99)02474-9","article-title":"Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum","volume":"858","author":"Rodriguez-Martinez","year":"2000","journal-title":"Brain Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000243650","article-title":"Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the NRF2-antioxidant response element pathway","volume":"18","author":"Tasset","year":"2010","journal-title":"Neurosignals"},{"key":"B162","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","volume":"8","author":"Franklin","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"B165","doi-asserted-by":"publisher","first-page":"21328","DOI":"10.3390\/ijms141121328","article-title":"Quinolinic acid: neurotoxin or oxidative stress modulator?","volume":"14","author":"Kubicova","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B166","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jorganchem.2015.01.030","article-title":"Effects of endogenous neurotoxin quinolinic acid on reactive oxygen species production by Fenton reaction catalyzed by iron or copper","volume":"782","author":"Kubicova","year":"2015","journal-title":"J Organomet Chem"},{"key":"B167","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats","volume":"224","author":"Pierozan","year":"2010","journal-title":"Exp Neurol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/brain\/awn119","article-title":"Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"131","author":"Anderson","year":"2008","journal-title":"Brain"},{"key":"B170","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yexcr.2014.02.024","article-title":"The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid","volume":"322","author":"Pierozan","year":"2014","journal-title":"Exp Cell Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jnr.23494","article-title":"Quinolinic acid induces disrupts cytoskeletal homeostasis in striatal neurons. Protective role of astrocyte-neuron interaction","volume":"93","author":"Pierozan","year":"2015","journal-title":"J Neurosci Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s11064-008-9619-7","article-title":"Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2+-ATPase function","volume":"33","author":"Fernandes","year":"2008","journal-title":"Neurochem Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J Neurol Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","article-title":"Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine","volume":"93","author":"Okuda","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B175","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J Neurochem"},{"key":"B176","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12640-009-9034-0","article-title":"5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones","volume":"15","author":"Smith","year":"2009","journal-title":"Neurotox Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tox.2003.08.007","article-title":"Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine","volume":"195","author":"Jeong","year":"2004","journal-title":"Toxicology"},{"key":"B178","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/IJTR.S2318","article-title":"Effects of kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons","volume":"2","author":"Braidy","year":"2009","journal-title":"Int J Tryptophan Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tibs.2004.01.007","article-title":"The new life of a centenarian: signalling functions of NAD(P)","volume":"29","author":"Berger","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"B180","doi-asserted-by":"publisher","first-page":"20408","DOI":"10.1074\/jbc.M109.016469","article-title":"Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"B181","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur J Neurosci"},{"key":"B182","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog Neurobiol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"B184","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int J Tryptophan Res"},{"issue":"Pt 1","key":"B185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj2910011","article-title":"4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells)","volume":"291","author":"Saito","year":"1993","journal-title":"Biochem J"},{"key":"B186","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1742-4658.2007.05635.x","article-title":"Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism","volume":"274","author":"Pucci","year":"2007","journal-title":"FEBS J"},{"key":"B187","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04301","article-title":"NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury","volume":"438","author":"Salter","year":"2005","journal-title":"Nature"},{"key":"B189","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nature04474","article-title":"NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia","volume":"439","author":"Micu","year":"2006","journal-title":"Nature"},{"key":"B190","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxic oligodendroglial death and demyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci"},{"key":"B191","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/nmt.14.40","article-title":"Remyelination in multiple sclerosis: what do we know and where are we going?","volume":"5","author":"Williams","year":"2015","journal-title":"Neurodegener Dis Manag"},{"key":"B192","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1469-7580.2007.00733.x","article-title":"Excitotoxic damage to white matter","volume":"210","author":"Matute","year":"2007","journal-title":"J Anat"},{"key":"B193","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.23-29-09519.2003","article-title":"Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors","volume":"23","author":"Sanchez-Gomez","year":"2003","journal-title":"J Neurosci"},{"key":"B194","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1097\/00001756-199808240-00014","article-title":"Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity","volume":"9","author":"McDonald","year":"1998","journal-title":"Neuroreport"},{"key":"B195","first-page":"365","article-title":"Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice","volume":"47","author":"Ziak","year":"1998","journal-title":"Physiol Res"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04302","article-title":"NMDA receptors are expressed in oligodendrocytes and activated in ischaemia","volume":"438","author":"Karadottir","year":"2005","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/glia.20608","article-title":"Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter","volume":"56","author":"Bakiri","year":"2008","journal-title":"Glia"},{"key":"B198","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0197-0186(95)00091-7","article-title":"The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits","volume":"28","author":"de Carvalho","year":"1996","journal-title":"Neurochem Int"},{"key":"B199","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat Med"},{"key":"B200","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/71548","article-title":"Autoimmune encephalomyelitis ameliorated by AMPA antagonists","volume":"6","author":"Smith","year":"2000","journal-title":"Nat Med"},{"key":"B201","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","article-title":"Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?","volume":"1","author":"Ikonomidou","year":"2002","journal-title":"Lancet Neurol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2005.12.002","article-title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","volume":"6","author":"Muir","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","author":"Lovelace","year":"2016","journal-title":"Neuropharmacology"},{"key":"B204","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.molmed.2013.03.004","article-title":"Therapies for multiple sclerosis: translational achievements and outstanding needs","volume":"19","author":"Haghikia","year":"2013","journal-title":"Trends Mol Med"},{"key":"B205","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bcp.2011.06.013","article-title":"Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10","volume":"82","author":"Hertenstein","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","article-title":"Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite","volume":"310","author":"Platten","year":"2005","journal-title":"Science"},{"key":"B207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1586\/17512433.2016.1108189","article-title":"Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis","volume":"9","author":"Constantinescu","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00415-014-7264-4","article-title":"A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J Neurol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.2769","article-title":"Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection","volume":"15","author":"Abtin","year":"2014","journal-title":"Nat Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ni.2584","article-title":"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells","volume":"14","author":"Roediger","year":"2013","journal-title":"Nat Immunol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nprot.2011.438","article-title":"Intravital multiphoton imaging of immune responses in the mouse ear skin","volume":"7","author":"Li","year":"2012","journal-title":"Nat Protoc"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00418-008-0531-7","article-title":"Visualizing dendritic cell migration within the skin","volume":"130","author":"Roediger","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nri1884","article-title":"Dynamic imaging of the immune system: progress, pitfalls and promise","volume":"6","author":"Germain","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1002\/0471142956.cy0209s54","article-title":"Multi-photon imaging","author":"Padmanabhan","year":"2010","journal-title":"Curr Protoc Cytom"},{"key":"B215","doi-asserted-by":"publisher","first-page":"e1004236","DOI":"10.1371\/journal.ppat.1004236","article-title":"Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis","volume":"10","author":"Pai","year":"2014","journal-title":"PLoS Pathog"},{"key":"B216","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fncel.2012.00067","article-title":"Visualizing leukocyte trafficking in the living brain with 2-photon intravital microscopy","volume":"6","author":"Pai","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"B217","doi-asserted-by":"publisher","first-page":"e2184","DOI":"10.3791\/2184","article-title":"Intravital microscopy of the mouse brain microcirculation using a closed cranial window","volume":"45","author":"Cabrales","year":"2010","journal-title":"J Vis Exp"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nprot.2009.89","article-title":"Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window","volume":"4","author":"Holtmaat","year":"2009","journal-title":"Nat Protoc"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"B221","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-065X.2006.00433.x","article-title":"Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors","volume":"213","author":"Mrass","year":"2006","journal-title":"Immunol Rev"},{"key":"B222","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nature11098","article-title":"Generalized Levy walks and the role of chemokines in migration of effector CD8+ T cells","volume":"486","author":"Harris","year":"2012","journal-title":"Nature"},{"key":"B223","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nri2971","article-title":"Illuminating viral infections in the nervous system","volume":"11","author":"McGavern","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awn354","article-title":"Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization","volume":"132","author":"Siffrin","year":"2009","journal-title":"Brain"},{"key":"B225","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature08478","article-title":"Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions","volume":"462","author":"Bartholomaus","year":"2009","journal-title":"Nature"},{"key":"B226","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/stem.194","article-title":"Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis","volume":"27","author":"Constantin","year":"2009","journal-title":"Stem Cells"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1172\/JCI67233","article-title":"2-Photon imaging of phagocyte-mediated T cell activation in the CNS","volume":"123","author":"Pesic","year":"2013","journal-title":"J Clin Invest"},{"key":"B228","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","article-title":"In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis","volume":"33","author":"Siffrin","year":"2010","journal-title":"Immunity"},{"key":"B229","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","article-title":"The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms","volume":"26","author":"Engelhardt","year":"2005","journal-title":"Trends Immunol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/NEN.0b013e31818f9ca8","article-title":"Perivascular spaces and the two steps to neuroinflammation","volume":"67","author":"Owens","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"e1003395","DOI":"10.1371\/journal.ppat.1003395","article-title":"Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system","volume":"9","author":"Nayak","year":"2013","journal-title":"PLoS Pathog"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1084\/jem.20050011","article-title":"Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion","volume":"201","author":"Kawakami","year":"2005","journal-title":"J Exp Med"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ncomms2230","article-title":"Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation","volume":"3","author":"Davalos","year":"2012","journal-title":"Nat Commun"},{"key":"B235","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1212\/01.wnl.0000203121.04509.31","article-title":"A phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses","volume":"66","author":"O\u2019Connor","year":"2006","journal-title":"Neurology"},{"key":"B236","doi-asserted-by":"crossref","DOI":"10.5772\/32332","article-title":"The kynurenine pathway","volume-title":"Amyotrophic Lateral Sclerosis","author":"Chen","year":"2012"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:41:24Z","timestamp":1718732484000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00246\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":236,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00246","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}